Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2010
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196514 Calcium silicate-based composite cement and methods for the preparation
08/05/2010US20100196497 Method of Treating Tissue Using Platelet-Rich Plasma in Combination with Low-Level Laser Therapy
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196489 Bone growth particles and osteoinductive composition thereof
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196427 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196404 Methods of use of the taci/taci-l interaction
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196333 Device and Process for Producing Fiber Products and Fiber Products Produced Thereby
08/05/2010US20100196331 Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
08/05/2010US20100196322 Polymer for tissue engineering applications and drug delivery
08/05/2010US20100196281 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/04/2010EP2214018A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
08/04/2010EP2212344A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
08/04/2010EP2212323A2 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212292A1 Amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2212290A1 Aryl amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2211878A2 Calcium-mediated effects of coral and methods of use thereof
08/04/2010EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN201537256U Chinese medicinal patch for treating hyperosteogeny
08/04/2010CN201536901U Neck pillow capable of placing auxiliary object
08/04/2010CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/04/2010CN101796072A Amino acid sequences directed against RANK-l and polypeptides comprising the same for the treatment of bone diseases and disorders
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795685A hydroxyproline compositions and uses thereof
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101791383A Compound chicory series product and effect of adjusting blood sugar, blood fat and blood uric acid
08/04/2010CN101791367A Traditional Chinese medicine plaster for activating blood circulation and relieving pain
08/04/2010CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera
08/04/2010CN101791357A Externally-applied ointment for treatment of lumbar disc herniation and preparation method thereof
08/04/2010CN101791344A Traditional Chinese medicine and preparation method thereof
08/04/2010CN101791341A Application of traditional Chinese medicine composition in preparing drug for treatment of osteoporosis
08/04/2010CN101791318A Novel application of bacterial lipopolysaccharides
08/04/2010CN101791317A Compound preparation for treating knee osteoarthritis
08/04/2010CN101791288A Stable lenalidomide oral solid preparation
08/04/2010CN101791150A Production method of silica gel sheet containing traditional Chinese medicines and being used for the health underpants
08/04/2010CN101249187B Chinese medicine for curing neck protrusion of lumbar vertebral disc
08/04/2010CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof
08/04/2010CN101057959B Medicinal composition for treating derangement syndrome of small joints in lumbar spine and waist support
08/03/2010US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767665 1,3-benzothiazinone derivatives and use thereof
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
08/03/2010CA2306343C Novel aryloxy-alkyl-dialkylamines
08/03/2010CA2294101C A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor
07/2010
07/29/2010WO2010085158A1 Improved animal treatment
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084851A1 Peptide capable of binding to immunoglobulin
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084661A1 Composition, food, food material, pharmaceutical preparation, cosmetic and commodity each containing isothiocyanate compound
07/29/2010WO2010084500A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
07/29/2010WO2010083752A1 High-purity febuxostat and the method for preparation
07/29/2010WO2010083581A1 Method for preparing an immunostimulant from a brucella lysate, and product
07/29/2010WO2010083573A1 The treatment or prophylaxis of organ and tissue fibrosis via modulation of cell division autoantigen (cda1)
07/29/2010WO2010064012A3 Treatment of autoimmune disease by modulating annexin-i (lipocortin 1 )
07/29/2010WO2010056877A3 Haloalkyl containing compounds as cysteine protease inhibitors
07/29/2010WO2010054321A3 Methods of treating autoimmune disorders and/or inflammatory disorders
07/29/2010WO2010039920A3 Boldine compounds for promoting bone growth
07/29/2010US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof
07/29/2010US20100190813 Spiro [piperidine-4- 4' -thieno [3,2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
07/29/2010US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors
07/29/2010US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis
07/29/2010US20100190805 Preparation for the treatment of equine laminitis
07/29/2010US20100190799 Phenazine compounds and use thereof in autoimmune and inflammatory diseases
07/29/2010US20100190798 Pharmaceutical composition comprising racemic aminopterin
07/29/2010US20100190790 Sigma receptor inhibitors
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100190786 Indolin-2-ones and aza-indolin-2-ones
07/29/2010US20100190776 Thiazoline and Oxazoline Derivatives and Their Methods of Use
07/29/2010US20100190773 Anti-Cytokine Heterocyclic Compounds
07/29/2010US20100190755 Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
07/29/2010US20100190750 GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto
07/29/2010US20100190696 Treatment of t-cell mediated diseases
07/29/2010US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
07/29/2010US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/29/2010US20100189770 Bioerodible patch
07/29/2010US20100189720 Novel card proteins involved in cell death regulation
07/29/2010US20100189714 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/29/2010CA2750457A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
07/29/2010CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/28/2010EP2210956A2 Method to inhibit cell growth using oligonucleotides
07/28/2010EP2210604A1 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases
07/28/2010EP2210507A1 Bone-strengthening food material
07/28/2010EP2210092A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
07/28/2010EP2209805A1 An antigen associated with rheumatoid arthritis
07/28/2010EP2209771A1 Cyclobutyl carboxylic acid derivatives